Actavia Life Sciences (CE) Aktie - RASP

Professionelle Tools für Privatanleger.

Premium

Current Price

0,004

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,0016 52-Wochen-Bereich 0,039

Marktkapitalisierung

3,087M

Handelsende

0,004

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

771.811.360

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

-0,01

Erlöse

Nettogewinn

-4,44M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Hauptsitz

Reno, Nevada, USA

Gegründet

Actavia Life Sciences Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RASP. The last closing price for Actavia Life Sciences (CE) was US$0,00. Over the last year, Actavia Life Sciences (CE) shares have traded in a share price range of US$ 0,0016 to US$ 0,039.

Actavia Life Sciences (CE) currently has 771.811.360 shares in issue. The market capitalisation of Actavia Life Sciences (CE) is US$3,09 million. Actavia Life Sciences (CE) has a price to earnings ratio (PE ratio) of 0.00.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0.004	0.004	0.004	0	0	CS
52	-0.015	-78.9473684211	0.019	0.039	0.0016	10184	0.00980985	CS
156	-0.026	-86.6666666667	0.03	0.05	0.0001	13907	0.02157236	CS
260	-0.026	-86.6666666667	0.03	0.33	0.0001	29030	0.0475913	CS

RASP - Frequently Asked Questions (FAQ)

What is the current Actavia Life Sciences (CE) share price?

The current share price of Actavia Life Sciences (CE) is US$ 0,004

How many Actavia Life Sciences (CE) shares are in issue?

Actavia Life Sciences (CE) has 771.811.360 shares in issue

What is the market cap of Actavia Life Sciences (CE)?

The market capitalisation of Actavia Life Sciences (CE) is USD 3,09M

What is the 1 year trading range for Actavia Life Sciences (CE) share price?

Actavia Life Sciences (CE) has traded in the range of US$ 0,0016 to US$ 0,039 during the past year

What is the reporting currency for Actavia Life Sciences (CE)?

Actavia Life Sciences (CE) reports financial results in USD

What is the latest annual profit for Actavia Life Sciences (CE)?

The latest annual profit of Actavia Life Sciences (CE) is USD -4,44M

What is the registered address of Actavia Life Sciences (CE)?

The registered address for Actavia Life Sciences (CE) is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501

Which industry sector does Actavia Life Sciences (CE) operate in?

Actavia Life Sciences (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
NXGBNxGen Brands Inc (CE)	US$ 0,003 (299.900,00%)	180,55k
DOCKFBeyond Med Technologies Inc (PK)	US$ 0,055 (54.900,00%)	3,05k
SDCCQSmileDirectClub Inc (CE)	US$ 0,0004 (39.900,00%)	52,05k
LTFDLittlefield Corporation (CE)	US$ 0,1525 (38.025,00%)	240
SGMDSugarmade Inc (CE)	US$ 0,0003 (29.900,00%)	5,94k
RTNBroot9B Holdings Inc (CE)	US$ 0,000001 (-99,97%)	666
THMOThermoGenesis Holdings Inc (CE)	US$ 0,000001 (-99,86%)	250
DOMWFPrime Drink Group Corporation (PK)	US$ 0,0012 (-99,08%)	311,03k
TTCMTautachrome Inc (CE)	US$ 0,000001 (-99,00%)	125,07k
MITJFMint Corporation (CE)	US$ 0,0001 (-99,00%)	12k
HCMCHealthier Choices Management Corporation (PK)	US$ 0,000001 (0,00%)	316,07M
HMBLHUMBL Inc (PK)	US$ 0,0007 (0,00%)	218,85M
GRLFGreen Leaf Innovations Inc (PK)	US$ 0,00015 (-25,00%)	210,68M
RONNRonn Motor Group Inc (PK)	US$ 0,0003 (0,00%)	171,31M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,00275 (-1,79%)	134,31M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Actavia Life Sciences Inc (CE) (RASP)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Actavia Life Sciences Inc (CE)

RASP Neueste Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

RASP - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Actavia Life Sciences Inc (CE) (RASP) Börsenkurse

Actavia Life Sciences Inc (CE) (RASP)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Actavia Life Sciences Inc (CE)

RASP Neueste Nachrichten

RASP - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen